Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
A Peninsula drug developer's stock ballooned more than 100% in after-hours trading Monday after it disclosed early data from a midstage clinical trial of a drug designed to treat the autoimmune kidney disease lupus nephritis. Kezar Life Sciences Inc. (NASDAQ: KZR) said lupus nephritis patients responded well — including some with a complete response — after 24 weeks of treatment with the company's drug zetomipzomib. Lupus nephritis is a type of kidney disease caused by systemic lupus, where… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 28, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news

Continuing, Stopping Immunosuppression Tested in Lupus Nephritis Continuing, Stopping Immunosuppression Tested in Lupus Nephritis
Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news

What Is the Most Common Type of Lupus Nephritis?
Title: What Is the Most Common Type of Lupus Nephritis?Category: Diseases and ConditionsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/7/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 7, 2022 Category: Rheumatology Source Type: news

What Are the 6 Types of Lupus Nephritis?
Title: What Are the 6 Types of Lupus Nephritis?Category: Diseases and ConditionsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/7/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 7, 2022 Category: Rheumatology Source Type: news

Tacrolimus Measures Up in Lupus Nephritis Trial
(MedPage Today) -- In a phase III trial, oral tacrolimus (Prograf) proved non-inferior to intravenous cyclophosphamide for treating lupus nephritis, researchers said. Among 158 patients randomized to tacrolimus, 83.0% achieved complete or partial... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 30, 2022 Category: Rheumatology Source Type: news

What Are the Symptoms for Lupus Nephritis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 25, 2022 Category: General Medicine Source Type: news

Who Is Most Likely to Get Lupus Nephritis? Symptoms
Title: Who Is Most Likely to Get Lupus Nephritis? SymptomsCategory: Diseases and ConditionsCreated: 3/16/2022 12:00:00 AMLast Editorial Review: 3/16/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 16, 2022 Category: Rheumatology Source Type: news

Biocon Biologics says clinical study for drug Itolizumab initiated in India after approval from DCGI
Biocon's partner US-based Equillium Inc has expanded its 'EQUALISE' study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab to clinical centers in India, Biocon Ltd said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 23, 2021 Category: Pharmaceuticals Source Type: news

How Long Can You Live With Lupus Nephritis?
Title: How Long Can You Live With Lupus Nephritis?Category: Diseases and ConditionsCreated: 12/9/2021 12:00:00 AMLast Editorial Review: 12/9/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 9, 2021 Category: Nutrition Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Experts Debate Merits of Dual Therapy for Lupus Nephritis Experts Debate Merits of Dual Therapy for Lupus Nephritis
Brad Rovin, MD, and Richard Furie, MD, discussed the merits of dual therapy with voclosporin or belimumab in lupus nephritis but said response rates leave a lot of room for improvement.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 19, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Add-On Voclosporin Improves Outcome in Lupus Nephritis Add-On Voclosporin Improves Outcome in Lupus Nephritis
Voclosporin plus MMF and low-dose corticosteroids improves renal response rates compared with use of these agents alone in patients with in lupus nephritis, according to a company-funded study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

How Is Lupus Nephritis Treated
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 12, 2021 Category: General Medicine Source Type: news

What Are The Six Classes of Lupus Nephritis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 7, 2021 Category: General Medicine Source Type: news

B Cells in Relapsing Lupus Nephritis and Cutaneous Vasculitis B Cells in Relapsing Lupus Nephritis and Cutaneous Vasculitis
A case of a woman with systemic lupus erythematosus whose nephritis and cutaneous vasculitis were refractory to treatment.HSS Grand Rounds Complex Cases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 28, 2021 Category: Consumer Health News Tags: Rheumatology Clinical Case Source Type: news